Equities

Shanghai MicroPort MedBot Group Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Shanghai MicroPort MedBot Group Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (HKD)23.88
  • Today's Change-0.40 / -1.65%
  • Shares traded6.71m
  • 1 Year change+12.91%
  • Beta1.3928
Data delayed at least 15 minutes, as of Mar 04 2026 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shanghai MicroPort MedBot Group Co Ltd is a China-based company primarily engaged in the provision of intelligent surgery total solutions. The Company’s main business is engaged in the research and development, manufacturing and sale of surgical robots. The Company’s products include Toumai Laparoscopic Surgical Robot, Skywalker Orthopedic Surgical Robot, R-one vascular intervention surgical robot, Microport Medbot and other products, covering surgical specialties of laparoscopic, orthopedic, panvascular, natural orifice and percutaneous surgical procedures. The Company conducts its business in the domestic and overseas markets.

  • Revenue in HKD (TTM)379.22m
  • Net income in HKD-543.88m
  • Incorporated2015
  • Employees440.00
  • Location
    Shanghai MicroPort MedBot Group Co LtdRoom 101, Area B, Building 1601 Zhangdong Road, China (Shanghai)Pilot Free Trade ZoneSHANGHAI 201203ChinaCHN
  • Phone+86 2 138954600
  • Websitehttps://www.medbotsurgical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Heron Neutron Medical Corp1.36m-115.83m19.50bn65.00--6.50--14,337.41-3.51-3.510.040977.370.0008--3.5585,015.38-6.86---6.88---379.50---8,516.20--449.62--0.0007---100.00---105.77------
QingSong Health Corp1.42bn91.42m19.60bn205.00214.34--202.2813.840.4430.4436.86-6.23------7,260,856.00--------32.06--6.46------3.27--92.87---90.75------
Shandong Weigao Group Medical Polymer Co14.88bn2.24bn22.37bn13.06k10.090.82286.431.500.48970.48973.266.000.37052.872.051,170,045.005.857.587.389.8349.6952.8115.7818.243.3216.680.176633.39-1.084.743.242.24-8.0513.11
Autobio Diagnostics Co Ltd4.77bn1.24bn22.81bn5.77k18.362.31--4.781.921.927.3715.310.3651.583.55730,698.709.5411.2712.0714.1963.2861.7526.1426.612.13--0.007848.990.619910.78-1.899.06-2.71--
Shenzhen Edge Medical Co Ltd317.21m-198.91m23.90bn----17.57--75.36-0.513-0.5130.81813.47----------------61.90---62.70--10.86--0.0114--233.03---2.65------
Alfresa Holdings Corporation151.50bn1.66bn24.53bn12.45k14.000.948410.160.1619185.04185.0416,819.642,732.391.9014.394.14245,889,200.002.112.056.105.337.077.171.111.021.02--0.056942.103.591.87-7.34-7.42-0.43934.73
Shanghai MicroPort MedBot Group Co Ltd379.22m-543.88m25.04bn440.00--41.18--66.03-0.5529-0.55290.38170.58960.25451.117.18842,715.10-36.76-42.31-62.94-52.8733.1828.11-144.46-936.401.45-26.620.5653--145.95--36.53--62.90--
Ansell Ltd15.57bn1.05bn25.17bn15.72k24.301.6415.211.621.311.3119.4519.460.60932.119.25180,289.004.145.334.866.3842.1638.276.807.981.138.620.293948.3023.714.4232.81-8.531.350.4863
Zhende Medical Co Ltd4.89bn317.72m26.78bn7.81k84.494.16--5.481.051.0516.2221.400.53113.706.19553,702.603.5715.124.5620.1632.1937.756.7216.681.23--0.190630.863.3217.9594.1419.6822.9616.18
MGI Tech Co Ltd3.41bn-290.70m27.32bn2.60k--3.13--8.02-0.6175-0.61757.2318.550.30021.282.371,156,828.00-2.623.69-3.035.1349.7758.81-8.749.123.67--0.116719.123.4822.521.10--12.79--
Shanghai Conant Optical Co Ltd2.46bn559.59m29.40bn2.95k45.799.7445.2111.931.271.275.595.960.79882.465.61905,042.1018.1414.7723.7120.6339.5236.6922.7116.802.79--0.084519.9417.1114.2530.9630.7931.32--
iRay Group2.29bn617.12m29.85bn1.66k46.204.34--13.042.702.7010.0328.740.20731.252.74--5.419.746.0311.1747.8654.6826.1133.283.25--0.385132.63-1.7427.38-23.4337.00104.75--
Data as of Mar 04 2026. Currency figures normalised to Shanghai MicroPort MedBot Group Co Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

5.37%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 04 Feb 202614.82m1.45%
Global X Management Co. LLCas of 05 Feb 202612.18m1.19%
Handelsbanken Fonder ABas of 31 Jan 20267.54m0.74%
BlackRock Fund Advisorsas of 06 Feb 20264.90m0.48%
Raiffeisen Kapitalanlage-Gesellschaft mbHas of 30 Sep 20254.30m0.42%
Bosera Asset Management Co., Ltd.as of 30 Jun 20253.07m0.30%
Norges Bank Investment Managementas of 30 Jun 20252.68m0.26%
BlackRock Advisors (UK) Ltd.as of 06 Feb 20261.92m0.19%
China Asset Management Co., Ltd.as of 30 Jun 20251.85m0.18%
China Asset Management (Hong Kong) Ltd.as of 30 Jan 20261.78m0.17%
More ▼
Data from 31 Dec 2025 - 20 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.